DiaMedica Therapeutics Inc. Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 3 rows, 3 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-12-06: Reporting owner Pauls Dietrich John; Form 3; Security Warrant; Transaction Holding.
- 2018-12-06: Reporting owner Kellen Scott; Form 3; Security Warrant; Transaction Holding.
- 2018-12-06: Reporting owner Giuffre Randall Michael; Form 3; Security Warrant; Transaction Holding.
DMAC insiders stock price
Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
No transaction of this security type is retained for this issuer, so the price history carries no markers. The chart is the same one every issuer renders.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-12-06 holding as of filing | Pauls Dietrich John Director, Officer (President and CEO) | 3 | Warrant Derivative · Direct | Holding | $7.00 exercise price | 2018-12-06 | ||
| 2018-12-06 holding as of filing | Kellen Scott Officer (CFO and Secretary) | 3 | Warrant Derivative · Direct | Holding | $7.00 exercise price | 2018-12-06 | ||
| 2018-12-06 holding as of filing | Giuffre Randall Michael Director | 3 | Warrant Derivative · Direct | Holding | $7.00 exercise price | 2018-12-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |